ArticleSTAR protocols2026

Protocol for establishing a chemoresistant orthotopic triple-negative breast cancer patient-derived xenograft model for preclinical drug testing.

David Tébar-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.